Literature DB >> 12651596

Aberrant DNA methylation: have we entered the era of more than one type of colorectal cancer?

Barry Iacopetta1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12651596      PMCID： PMC1851227          DOI： 10.1016/S0002-9440(10)63900-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  17 in total

1.  Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer.

Authors:  H Elsaleh; D Joseph; F Grieu; N Zeps; N Spry; B Iacopetta
Journal:  Lancet       Date:  2000-05-20       Impact factor: 79.321

2.  Serrated route to colorectal cancer: back street or super highway?

Authors:  J R Jass
Journal:  J Pathol       Date:  2001-03       Impact factor: 7.996

3.  CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.

Authors:  Nicholas Hawkins; Mark Norrie; Kay Cheong; Elisa Mokany; Su-Lyn Ku; Alan Meagher; Terence O'Connor; Robyn Ward
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene.

Authors:  L L Stern; J B Mason; J Selhub; S W Choi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-08       Impact factor: 4.254

5.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.

Authors:  M van Rijnsoever; F Grieu; H Elsaleh; D Joseph; B Iacopetta
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

6.  Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.

Authors:  N J Hawkins; R L Ward
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

7.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 8.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

9.  Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.

Authors:  Maria F Paz; Sonia Avila; Mario F Fraga; Marina Pollan; Gabriel Capella; Miquel Angel Peinado; Montserrat Sanchez-Cespedes; James G Herman; Manel Esteller
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.

Authors:  B G Taal; H Van Tinteren; F A Zoetmulder
Journal:  Br J Cancer       Date:  2001-11-16       Impact factor: 7.640
View more
  2 in total

1.  Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma.

Authors:  M Pufulete; R Al-Ghnaniem; A Khushal; P Appleby; N Harris; S Gout; P W Emery; T A B Sanders
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.

Authors:  Sang-Jeon Lee; Song Yi Choi; Wun-Jae Kim; Meiying Ji; Taek-Gu Lee; Bo-Ra Son; Soon Man Yoon; Rohyun Sung; Eun Jeoung Lee; Sei Jin Youn; Seon Mee Park
Journal:  Diagn Pathol       Date:  2013-06-19       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.